Here is the number that organizes everything else: 114%.
That is how much the average subsidized ACA enrollee's annual premium payment rose in 2026, from about $888 to about $1,904, according to KFF, after the enhanced premium tax credits expired at the end of 2025. Those credits had been reducing premiums for roughly 22 million people, more than 90% of everyone on the marketplace.
The political story is well told by now. Democrats forced a 43-day government shutdown over the extension. Moderate Republicans warned about the midterms. Trump floated a compromise and then backed away. The Senate rejected two competing bills in December and the credits lapsed overnight.
What almost nobody says out loud is that the entire fight, on both sides, concerns who receives the invoice. Not one serious proposal on the table in December would have reduced the underlying price of American health insurance by a dollar.
The subsidies were a blindfold, and it came off
Buried in KFF's methodology is a line that deserves more attention than the headline it supports. In estimating 2026 costs, the analysts assumed the average unsubsidized premium would run about 18% higher than in 2025, based on insurer rate filings.
Eighteen percent. That increase had nothing to do with the tax credits. It happened underneath them, and it would have happened whether Congress extended them or not. In Pennsylvania, regulators approved 2026 marketplace increases running as high as 38%.
The enhanced credits did not make insurance cheap. They made it invisible. They capped what an enrollee could be asked to pay as a share of income, which meant that when the sticker price climbed, the federal government absorbed the difference and the household felt nothing. The mechanism worked exactly as designed, and its design ensured that the people best positioned to be angry about medical prices were the people least exposed to them.
Take the blindfold off and everyone sees the price at once. That is what happened on January 1. It felt like a cost increase. It was mostly a disclosure.
What the disclosure revealed
People are leaving.
Early CMS data suggests at least 1.5 million people dropped out of the marketplace for 2026, ending years of enrollment growth. The Urban Institute expects the final figure to approach 5 million going uninsured. CBO had projected around 4 million. An Urban Institute and Commonwealth Fund analysis put it at 4.8 million.
The 400% subsidy cliff is back, too, which means a single person earning about $63,000 gets nothing, while someone earning $62,000 gets help. The couple outside Atlanta whose premium went from $162 to $483 a month, on an income near $30,000, is not an outlier. They are the design.
And the people who leave first are the healthy ones, because they are the ones for whom the math most obviously fails. That leaves a smaller, sicker pool, which raises next year's premiums, which prompts more healthy people to leave. The adverse selection spiral is not a hypothetical risk in a think tank memo. It is the predictable second act, and it is already in progress.
The part that is not about the ACA at all
If this were purely a marketplace problem, you could fix it with a marketplace policy.
It is not. Average family premiums for employer-sponsored insurance have passed $25,000 a year, with workers paying thousands of that directly, on top of deductibles and copays that have quietly made "insured" and "able to afford care" into two different conditions. The employer market covers roughly 165 million people and gets almost none of the political oxygen, because its cost increases arrive as suppressed wages and fatter deductibles rather than as a line item somebody has to vote on.
The ACA marketplace is simply where the price of American health care is legible. It is the one place where the number appears on a screen, attached to a name, once a year, in public. That is why the crisis looks like an ACA crisis. It is a pricing crisis with an ACA-shaped window.
What restoring the credits would and would not do
It would help millions of people immediately, and that is not a small thing. Someone choosing between a premium and a mortgage does not need a lecture about structural cost drivers.
But it would also restore the blindfold. It would return to a system in which hospital prices, drug prices and insurer administrative costs can rise 8% or 18% a year while the people paying for them are shielded from noticing, and the bill migrates to the federal deficit, where it becomes an abstraction that gets cut during the next reconciliation fight. That is the deal on offer from the Democratic side.
The Republican alternative rejected in December, expanded health savings accounts, does something arguably worse. It hands people a tax-advantaged bucket and tells them to shop, in a market where prices are not published, quality is not comparable, and the goods are frequently purchased unconscious in an ambulance.
Neither is a cost policy. Both are financing policies wearing a cost policy's clothes.
The thing the enrollees keep saying
The most quoted line from the January coverage came from a 58-year-old enrollee in Wisconsin, talking to the AP, who said both parties have spent years promising to fix it, that they should get to the root cause, and that no party ever does.
He is right, and the reason is not mysterious. The root cause is prices, and prices are somebody's revenue. Every dollar of American health care overspending is a dollar of income for a hospital system, a drugmaker, a device firm, an insurer, a private equity roll-up, or a physician specialty with a good lobby. Reducing the bill means telling one of them no, and telling them no is a fight with an actual, well-funded opponent, whereas arguing about tax credits is a fight with the other party, which is easier and produces better fundraising emails.
So we will get a vote, probably. The credits may even come back, before November, because 5 million newly uninsured voters is a hard thing to run against.
And the premium underneath will keep rising 8% or 18% a year, and in three or four years the subsidy will need to be bigger again, and we will do this all over, and everyone in Washington will call it an affordability crisis, which it is, in the way that a fever is an illness.